These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18533961)

  • 1. Factor VII deficiency associated with valproate treatment.
    Unalp A; Dirik E; Kurul S
    Pediatr Int; 2008 Jun; 50(3):403-5. PubMed ID: 18533961
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial.
    Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR
    Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of epileptic seizures resistant to phenobarbital in children during the first year of life].
    Rudenko AIu; Konoplianko TV; Stetsiuk RA
    Lik Sprava; 2002; (1):52-6. PubMed ID: 11944381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine deficiency associated with anticonvulsant therapy.
    Rodriguez-Segade S; de la Peña CA; Tutor JC; Paz JM; Fernandez MP; Rozas I; Del Río R
    Clin Chim Acta; 1989 May; 181(2):175-81. PubMed ID: 2500272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic encephalopathy precipitated by sodium valproate therapy.
    Subhash HS; Heddle RJ; Schultz DW; Ring J; Thompson CH
    Med J Aust; 2008 May; 188(9):549. PubMed ID: 18459937
    [No Abstract]   [Full Text] [Related]  

  • 6. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
    Rigamonti A; Lauria G; Grimod G; Bianchi G; Salmaggi A
    J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case with Stevens Johnson syndrome triggered by combination of clobazam, lamotrigine, and valproic acid treatment.
    Ertam I; Sezgin AO; Unal I
    Int J Dermatol; 2009 Jan; 48(1):98-9. PubMed ID: 19126064
    [No Abstract]   [Full Text] [Related]  

  • 8. Rare magnetic resonance imaging findings in medium-chain acyl-coenzyme A dehydrogenase deficiency.
    Das S; Joardar S; Chatterjee R; Guha G; Hashmi MA
    Pediatr Neurol; 2011 Sep; 45(3):203-5. PubMed ID: 21824573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of drugs used in the treatment of acute convulsions and convulsive status].
    Herranz JL; Argumosa A
    Rev Neurol; 2000 Oct 16-31; 31(8):757-62. PubMed ID: 11082886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic therapy of seizures in the elderly.
    Mancall EL; Covington TR; Alonso RJ
    Hosp Pract (Off Ed); 1984 Nov; 19(11):223, 227, 231 passim. PubMed ID: 6436269
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of the immunosuppressive effect of some anticonvulsants in children].
    Massimo L; Pasino M; Rosanda Vadalá C; Tonini GP; Perutelli P; Saccomani L
    Minerva Pediatr; 1977 Apr; 29(12):837-41. PubMed ID: 327255
    [No Abstract]   [Full Text] [Related]  

  • 12. Protein C deficiency related to valproic acid therapy: a possible association with childhood stroke.
    Gruppo R; Degrauw A; Fogelson H; Glauser T; Balasa V; Gartside P
    J Pediatr; 2000 Nov; 137(5):714-8. PubMed ID: 11060540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice.
    Tutka P; Łuszczki J; Kleinrok Z; Arent K; Wielosz M
    J Neural Transm (Vienna); 2002 Apr; 109(4):455-66. PubMed ID: 11956965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine deficiency during valproic acid treatment.
    Van Wouwe JP
    Int J Vitam Nutr Res; 1995; 65(3):211-4. PubMed ID: 8830002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate: a simple chemical with so much to offer.
    Peterson GM; Naunton M
    J Clin Pharm Ther; 2005 Oct; 30(5):417-21. PubMed ID: 16164485
    [No Abstract]   [Full Text] [Related]  

  • 16. Unmasking of absence seizures by carbamazepine.
    Aithala G; Sztriha L
    Clin Pediatr (Phila); 2002 Mar; 41(2):119-20. PubMed ID: 11931329
    [No Abstract]   [Full Text] [Related]  

  • 17. Generalized onycholysis associated with sodium valproate therapy.
    Grech V; Vella C
    Eur Neurol; 1999 Jul; 42(1):64-5. PubMed ID: 10523137
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of immunotropic drugs on the anticonvulsive action of diazepam, phenobarbital, carbamazepine and valproate against maximal electroshock-induced convulsions in mice.
    Korobowicz A
    Pol J Pharmacol; 1998; 50(1):88. PubMed ID: 9662746
    [No Abstract]   [Full Text] [Related]  

  • 19. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S; Radhakrishnan K
    J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Febrile convulsions.
    Procopis PG
    Aust Fam Physician; 1983 Sep; 12(9):699-701. PubMed ID: 6418124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.